Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Milo Gatti

Showing results (121-130 of 168) with videos related to

Pageof 17
Sort By:
The Pediatric Infectious Disease Journal|July 31, 2023
Relationship Between Real-time TDM-guided Pharmacodynamic Target Attainment of Continuous Infusion Beta-lactam Monotherapy and Microbiologic Outcome in the Treatment of Critically Ill Children With Severe Documented Gram-negative InfectionsMilo Gatti, Caterina Campoli, Maria Elena Latrofa, et al.
Journal of Chemotherapy (Florence, Italy)|April 12, 2017
Septic shock due to NSTI caused by Actinomyces Turicensis: the role of clinical pharmacology. Case report and review of the literatureMilo Gatti, Laura Elisa Gasparini, Chiara Maria Grimaldi, et al.
Journal of Medical Microbiology|January 7, 2020
<i>In vivo</i> acquisition and risk of inter-species spread of <i>bla</i> <sub>KPC-3</sub>-plasmid from <i>Klebsiella pneumoniae</i> to <i>Serratia marcescens</i> in the lower respiratory tractAlessandra Bielli, Aurora Piazza, Valeria Cento, et al.
Antibiotics (Basel, Switzerland)|March 25, 2022
Orthopaedic Implant-Associated Staphylococcal Infections: A Critical Reappraisal of Unmet Clinical Needs Associated with the Implementation of the Best Antibiotic ChoiceMilo Gatti, Simona Barnini, Fabio Guarracino, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|March 7, 2019
Intensive multidisciplinary management in critical care patients affected by severe necrotizing soft tissue infections: a cooperative method to improve the efficacy of treatmentMilo Gatti, Laura Elisa Gasparini, Matteo Laratta, et al.
Expert Opinion on Drug Safety|December 25, 2023
Safety and effectiveness of fifth generation cephalosporins for the treatment of methicillin-resistant staphylococcus aureus bloodstream infections: a narrative review exploring past, present, and futureDavide Fiore Bavaro, Alessandra Belati, Linda Bussini, et al.
Antibiotics (Basel, Switzerland)|November 27, 2021
Assessment of a PK/PD Target of Continuous Infusion Beta-Lactams Useful for Preventing Microbiological Failure and/or Resistance Development in Critically Ill Patients Affected by Documented Gram-Negative InfectionsMilo Gatti, Pier Giorgio Cojutti, Renato Pascale, et al.
Frontiers in Pharmacology|December 27, 2021
Impact of Maximizing Css/MIC Ratio on Efficacy of Continuous Infusion Meropenem Against Documented Gram-Negative Infections in Critically Ill Patients and Population Pharmacokinetic/Pharmacodynamic Analysis to Support Treatment OptimizationPier Giorgio Cojutti, Milo Gatti, Matteo Rinaldi, et al.
International Journal of Antimicrobial Agents|December 4, 2022
A descriptive pharmacokinetic/pharmacodynamic analysis of continuous infusion ceftazidime-avibactam in a case series of critically ill renal patients treated for documented carbapenem-resistant Gram-negative bloodstream infections and/or ventilator-associated pneumoniaMilo Gatti, Renato Pascale, Pier Giorgio Cojutti, et al.
Pharmaceutics|August 26, 2022
Relationship between Pharmacokinetic/Pharmacodynamic Target Attainment and Microbiological Outcome in Critically Ill COVID-19 Patients with Documented Gram-Negative Superinfections Treated with TDM-Guided Continuous-Infusion MeropenemMaria Sanz Codina, Milo Gatti, Carla Troisi, et al.
Pageof 17

Showing results (121-130 of 168) with videos related to

Sort By:
Pageof 17
The Pediatric Infectious Disease Journal|July 31, 2023
Relationship Between Real-time TDM-guided Pharmacodynamic Target Attainment of Continuous Infusion Beta-lactam Monotherapy and Microbiologic Outcome in the Treatment of Critically Ill Children With Severe Documented Gram-negative InfectionsMilo Gatti, Caterina Campoli, Maria Elena Latrofa, et al.
Journal of Chemotherapy (Florence, Italy)|April 12, 2017
Septic shock due to NSTI caused by Actinomyces Turicensis: the role of clinical pharmacology. Case report and review of the literatureMilo Gatti, Laura Elisa Gasparini, Chiara Maria Grimaldi, et al.
Journal of Medical Microbiology|January 7, 2020
<i>In vivo</i> acquisition and risk of inter-species spread of <i>bla</i> <sub>KPC-3</sub>-plasmid from <i>Klebsiella pneumoniae</i> to <i>Serratia marcescens</i> in the lower respiratory tractAlessandra Bielli, Aurora Piazza, Valeria Cento, et al.
Antibiotics (Basel, Switzerland)|March 25, 2022
Orthopaedic Implant-Associated Staphylococcal Infections: A Critical Reappraisal of Unmet Clinical Needs Associated with the Implementation of the Best Antibiotic ChoiceMilo Gatti, Simona Barnini, Fabio Guarracino, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|March 7, 2019
Intensive multidisciplinary management in critical care patients affected by severe necrotizing soft tissue infections: a cooperative method to improve the efficacy of treatmentMilo Gatti, Laura Elisa Gasparini, Matteo Laratta, et al.
Expert Opinion on Drug Safety|December 25, 2023
Safety and effectiveness of fifth generation cephalosporins for the treatment of methicillin-resistant staphylococcus aureus bloodstream infections: a narrative review exploring past, present, and futureDavide Fiore Bavaro, Alessandra Belati, Linda Bussini, et al.
Antibiotics (Basel, Switzerland)|November 27, 2021
Assessment of a PK/PD Target of Continuous Infusion Beta-Lactams Useful for Preventing Microbiological Failure and/or Resistance Development in Critically Ill Patients Affected by Documented Gram-Negative InfectionsMilo Gatti, Pier Giorgio Cojutti, Renato Pascale, et al.
Frontiers in Pharmacology|December 27, 2021
Impact of Maximizing Css/MIC Ratio on Efficacy of Continuous Infusion Meropenem Against Documented Gram-Negative Infections in Critically Ill Patients and Population Pharmacokinetic/Pharmacodynamic Analysis to Support Treatment OptimizationPier Giorgio Cojutti, Milo Gatti, Matteo Rinaldi, et al.
International Journal of Antimicrobial Agents|December 4, 2022
A descriptive pharmacokinetic/pharmacodynamic analysis of continuous infusion ceftazidime-avibactam in a case series of critically ill renal patients treated for documented carbapenem-resistant Gram-negative bloodstream infections and/or ventilator-associated pneumoniaMilo Gatti, Renato Pascale, Pier Giorgio Cojutti, et al.
Pharmaceutics|August 26, 2022
Relationship between Pharmacokinetic/Pharmacodynamic Target Attainment and Microbiological Outcome in Critically Ill COVID-19 Patients with Documented Gram-Negative Superinfections Treated with TDM-Guided Continuous-Infusion MeropenemMaria Sanz Codina, Milo Gatti, Carla Troisi, et al.
Pageof 17